Every year in Israel, about 2,500 new patients are diagnosed with prostate cancer. Prostate cancer is considered to be the second most common cause of cancer death among men in the Western world.

The disease causes the death of approximately 375,000 people worldwide each year. There are many treatment options for prostate cancer and the type of treatment is determined according to the stage of the disease, the patient's condition and wishes. The main importance of the test is to identify mutations in the BRCA gene in the tumor.